Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice

Cancer Research

Volumn 57, Issue 7, 1997, Pages 1312-1319

  Sun, Lin Quan ^a   Vogel, Charles André ^b   Mirimanoff, René Olivier ^a   Coucke, Philippe ^a   Slosman, Daniel O ^c   Mach, Jean Pierre ^b   Buchegger, Franz ^c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY; IODINE 131;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER RADIOTHERAPY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; RADIOTHERAPY; TIME FACTORS;

EID: 0030901552     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet, 346: 336-340, 1995
2. Mach, J-P., Pèlegrin, A., and Buchegger, F. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors. Curr. Opin. Immunol., 3: 685-693, 1991.
3. Goldenberg, D. M., and Schlom, J. The coming of age of cancer radioimmunoconjugates. Imrnunol. Today, 14: 5-7, 1993.
4. Buchsbaum, D. J. Experimental approaches to increase radiolabeled antibody localization in tumors. Cancer Res., 55: 5729-5732, 1995.
5. Knox, S. J. Overview of studies on experimental radioimmunotherapy. Cancer Res., 55: 5832s-5836s, 1995.
6. Goldenberg, D. M. Monoclonal antibodies in cancer detection and therapy. Am. J. Med., 94: 297-312, 1993.
7. Buchsbaum, D. J., Langmuir, V. K., and Wessels, B. W. Experimental radioimmunotherapy. Med. Phys. (NY), 20: 551-567, 1993.
8. Mello, A. M., Pauwels, E. K. J., and Cleton, F. J. Radioimmunotherapy: no news from the newcomer (Editorial). J. Cancer Res. Clin. Oncol., 720: 121-130, 1994.
9. Riethmüller, G., Schneider-Gädicke, E., Schlimok, G., Schmiegel, W., Raab, R., Höffken, K., Gruber, R., Pichlmaier, H., Hirche, H., Pichlmayr, R., Buggisch, P., and Witte, J. Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes'C colorectal carcinoma. Lancet, 343: 1177-1183, 1994.
10. Vitetta, E. S., and Uhr, J. W. Monoclonal antibodies as agonists: an expanded role for their use in cancer therapy. Cancer Res., 54: 5301-5309, 1994.
11. Suit, H. D. Local control and patient survival. Int. J. Radiat. Oncol. Biol. Phys., 23: 653-660, 1992.
12. Shrivastava, S., Schlom, J., Raubitschek, A., Molinolo, A., and Hand, P. H. Studies concerning the effect of external irradiation on localization of radiolabeled monoclonal antibody B72.3 to human colon carcinoma xenografts. Int. J. Radiat. Oncol. Biol. Phys., 16: 721-729, 1989.
13. Msirikale, J. S., Kein, J. L., Schroeder, J., and Order, S. E. Radiation enhancement of radiolabelled antibody deposition in tumors. Int. J. Radiat. Oncol. Biol. Phys., 13: 1839-1844, 1987.
14. Kalofonos, H., Rowlinson, G., and Epenetos, A. A. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation. Cancer Res., 50: 159-163, 1990.
15. Order, S. E., Stillwagon, G. B., Klein, J. L., Leichner, P. K., Siegelman, S. S., Fischman, E. K., Ettinger, D. S., Haulk, T., Kopher, K., Finney, K., Surdyke, M., Self, S., and Leibel, S. Iodine 131 antiferrin, a new treatment modality in hepatoma: a radiation therapy oncology group study. J. Clin. Oncol., 3: 1573-1582, 1985.
16. Maraveyas, A., Myers, M., Stafford, N., Rowlinson-Busza, G., Stewart, J. S., and Epenetos, A. A. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues. Cancer Res., 55: 1020-1027, 1995.
17. 131I and total body irradiation for treatment of disseminated cancer. Int. J. Radial. Oncol. Biol. Phys., 32: 713-721, 1995.
18. Wang, S., Quadri, S. M., Tang, X. Z., Stephens, L. C., Lollo, C. P., Bartholomew, R. M., and Vriesendorp, H. M. Liver toxicity induced by combined external-beam irradiation and radioimmunoglobulin therapy. Radiat. Res., 141: 294-302, 1995.
19. Buchegger, F., Rojas, A., Bischof Delaloye, A., Vogel, C. A., Mirimanoff, R-O., Coucke, P., Sun, L-Q., Raimondi, S., Denekamp, J., Pèlegrin, A., Delaloye, B., and Mach, J-P. Combined radioimmunotherapy and radiotherapy of human colon carcinoma grafted in nude mice. Cancer Res., 55: 83-89, 1995.
20. Mach, J-P., Carrel, S., Merenda, C., Sordat, B., and Cerottini, J-C. In vivo localisation of radiolabelled antibodies to carcinoembryonic antigen in human colon carcinoma grafted into nude mice. Nature (Lond.), 248: 704-706, 1974.
21. Buchegger, F., Vacca, A., Carrel, S., Schreyer, M., and Mach, J-P. Radioimmuno-therapy of human colon carcinoma by 131-I-labelled monoclonal anti-CEA antibodies in a nude mouse model. Int. J. Cancer, 41: 127-134, 1988.
22. Buchegger, F., Pfister, C., Fournier, K., Prevel, F., Schreyer, M., Carrel, S., and Mach, J-P. Ablation of human colon carcinoma in nude mice by 131-I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments, J. Clin. Invest, 83: 1449-1456, 1989.
23. Hammarstrom, S., Shively, J. E., Paxton, R. J., Beatty, B. G., Larson, A., Ghosh, R., Bormer, O., Buchegger, F., Mach, J-P., Burtin, P., Seguin, P., Darbouret, B., Degorce, F., Sertour, J., Jolu, J-P., Fuks, A., Kalthoff, H., Schmiegel, W., Arndt, R., Kloppel, G., von Kleist, S., Grunert, F., Schwarz, K., Matsuoka, Y., Kuroki, M., Wagener, C., Weber, T., Yachi, A., Imai, K., Hishikawa, N., and Tsujisaki, M. Antigenic sites in carcinoembryonic antigen. Cancer Res., 49: 4852-4858, 1989.
24. Vogel, C. A., Bischof Delaioye, A., Mach, J-P., Pèlegrin, A., Hardman, N., Delaloye, B., and Buchegger, F. Direct comparison of a radioiodinated intact chimeric anti-CEA Mab with its F(ab')2 fragment in nude mice bearing different colon cancer xenografts. Br. J. Cancer, 68: 684-690, 1993.
25. Buchegger, F., Chalandon, Y., Pèlegrin, A., Hardman, N., and Mach, J-P. Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments. J. Nucl. Med., 32: 1414-1421, 1991.
26. Johns, H- E., and Cunningham, J. R. The physics of radiology. In: M Friedman (ed.), Monograph in the Bannerstane Division of American Lectures in Radiation Therapy, pp. 564-574. Springfield, IL: Charles C. Thomas Publisher, 1978.
27. Hardman, N., Lee Gill, L., de Winter, R. F. J., Wagner, K., Hollis, M., Businger, F., Ammaturo, D., Buchegger F., Mach, J-P., and Heusser, C. Generation of a recombinant human-mouse chimaeric monoclonal antibody directed against human carcinoembryonic antigen. Int. J. Cancer, 44: 424-433, 1989.
28. Schlom, J., Molinolo, A., Simpson, J. F., Siler, K., Roselli, M. Hinkle, G., Houchens, D. P., and Colcher, D. Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy. J. Natl. Cancer Inst., 82: 763-771, 1990.
29. 131I-labeled monoclonal antibody CC49. Cancer Res., 55: 5881-5887, 1995.
30. Schaake-Koning, K., van den Bogaert, W., Dalesio, O., Festen, J., Hoogenhout, J., van Houtte, P., Kirkpatrick, A., Koolen, M., Maat, B., Nijs, A., Renaud, A., Rodrigus, P., Schuster-Uitterhoeve, L., Sculier, J-P., van Zandwijk, N., and Bartelink, H. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. New Engl. J. Med., 326: 524-530, 1992.
31. Thames, H. D., and Hendry, J. H. Biological and chemical modifiers of cell survival. In: H. D. Thames and J. H. Hendry (eds.) Fractionation in Radiotherapy, pp. 189-199. Philadelphia: Taylor & Francis, Inc., 1987.
32. Folli, S., Pèlegrin, A., Chalandon, Y., Yo, X., Buchegger, F., Lejeune, F., and Mach, J-P. Tumor necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by selective increase of vascular permeability. Int. J. Cancer, 53: 829-836, 1993.
33. Jain, R. K. Determinants of tumor blood flow: a review. Cancer Res., 48: 2641-2658, 1988.
34. Langmuir, V. K., Fowler, J. F., Knox, S. J., Wessels, B. W., Sutherland, R. M., and Wong, J. Y. C. Radiobiology of radiolabeled antibody therapy as applied to tumor dosimetry. Med. Phys. (NY), 20: 601-610, 1993.
35. Vogel, C-A., Galmiche, M. C., and Buchegger, F. Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice. Cancer Res., 57: 447-453, 1997.